nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—SLC22A11—Methotrexate—muscle cancer	0.237	0.307	CbGbCtD
Cefazolin—ABCC4—Methotrexate—muscle cancer	0.22	0.285	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—muscle cancer	0.138	0.178	CbGbCtD
Cefazolin—SLC22A6—Methotrexate—muscle cancer	0.0959	0.124	CbGbCtD
Cefazolin—ALB—Methotrexate—muscle cancer	0.0817	0.106	CbGbCtD
Cefazolin—Cheilitis—Dactinomycin—muscle cancer	0.00682	0.0347	CcSEcCtD
Cefazolin—PON1—bone marrow—muscle cancer	0.00522	0.167	CbGeAlD
Cefazolin—Induration—Etoposide—muscle cancer	0.00469	0.0239	CcSEcCtD
Cefazolin—PON1—head—muscle cancer	0.00462	0.147	CbGeAlD
Cefazolin—Nephropathy—Etoposide—muscle cancer	0.00441	0.0224	CcSEcCtD
Cefazolin—Anorectal discomfort—Etoposide—muscle cancer	0.00384	0.0195	CcSEcCtD
Cefazolin—Nephropathy toxic—Etoposide—muscle cancer	0.00365	0.0186	CcSEcCtD
Cefazolin—Aplastic anaemia—Dactinomycin—muscle cancer	0.00272	0.0138	CcSEcCtD
Cefazolin—Prothrombin level increased—Doxorubicin—muscle cancer	0.00265	0.0135	CcSEcCtD
Cefazolin—Nephropathy—Methotrexate—muscle cancer	0.00264	0.0134	CcSEcCtD
Cefazolin—Mouth ulceration—Dactinomycin—muscle cancer	0.00262	0.0133	CcSEcCtD
Cefazolin—Phlebitis—Dactinomycin—muscle cancer	0.00244	0.0124	CcSEcCtD
Cefazolin—Mouth ulceration—Vincristine—muscle cancer	0.00234	0.0119	CcSEcCtD
Cefazolin—SLC22A11—renal system—muscle cancer	0.00222	0.0708	CbGeAlD
Cefazolin—Lactic dehydrogenase activity increased—Doxorubicin—muscle cancer	0.00213	0.0108	CcSEcCtD
Cefazolin—TPMT—renal system—muscle cancer	0.0021	0.067	CbGeAlD
Cefazolin—Candida infection—Etoposide—muscle cancer	0.002	0.0102	CcSEcCtD
Cefazolin—Anorectal discomfort—Doxorubicin—muscle cancer	0.00199	0.0101	CcSEcCtD
Cefazolin—Local reaction—Doxorubicin—muscle cancer	0.00197	0.01	CcSEcCtD
Cefazolin—Mouth ulceration—Etoposide—muscle cancer	0.0019	0.00965	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.00189	0.00964	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00189	0.00964	CcSEcCtD
Cefazolin—TPMT—cardiac atrium—muscle cancer	0.00188	0.06	CbGeAlD
Cefazolin—Blood lactate dehydrogenase increased—Doxorubicin—muscle cancer	0.00187	0.00953	CcSEcCtD
Cefazolin—Liver disorder—Methotrexate—muscle cancer	0.00184	0.00938	CcSEcCtD
Cefazolin—Phlebitis—Etoposide—muscle cancer	0.00177	0.009	CcSEcCtD
Cefazolin—Thrombocytosis—Doxorubicin—muscle cancer	0.00175	0.0089	CcSEcCtD
Cefazolin—Pancytopenia—Dactinomycin—muscle cancer	0.00173	0.00879	CcSEcCtD
Cefazolin—Oral candidiasis—Doxorubicin—muscle cancer	0.00171	0.00872	CcSEcCtD
Cefazolin—Neutropenia—Dactinomycin—muscle cancer	0.0017	0.00865	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00169	0.00861	CcSEcCtD
Cefazolin—TPMT—tendon—muscle cancer	0.00164	0.0523	CbGeAlD
Cefazolin—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00161	0.00818	CcSEcCtD
Cefazolin—TPMT—bone marrow—muscle cancer	0.00159	0.0507	CbGeAlD
Cefazolin—Stomatitis—Dactinomycin—muscle cancer	0.00158	0.00804	CcSEcCtD
Cefazolin—Pancytopenia—Vincristine—muscle cancer	0.00154	0.00785	CcSEcCtD
Cefazolin—TPMT—vagina—muscle cancer	0.00152	0.0485	CbGeAlD
Cefazolin—Neutropenia—Vincristine—muscle cancer	0.00152	0.00773	CcSEcCtD
Cefazolin—Agranulocytosis—Dactinomycin—muscle cancer	0.00151	0.0077	CcSEcCtD
Cefazolin—Hepatitis—Dactinomycin—muscle cancer	0.00146	0.00741	CcSEcCtD
Cefazolin—Stomatitis—Vincristine—muscle cancer	0.00141	0.00719	CcSEcCtD
Cefazolin—TPMT—head—muscle cancer	0.0014	0.0448	CbGeAlD
Cefazolin—Erythema multiforme—Dactinomycin—muscle cancer	0.00138	0.007	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00137	0.00698	CcSEcCtD
Cefazolin—TPMT—testis—muscle cancer	0.00136	0.0433	CbGeAlD
Cefazolin—Blood disorder—Doxorubicin—muscle cancer	0.0013	0.00663	CcSEcCtD
Cefazolin—ABCC4—renal system—muscle cancer	0.00126	0.0403	CbGeAlD
Cefazolin—Vaginal inflammation—Methotrexate—muscle cancer	0.00126	0.00639	CcSEcCtD
Cefazolin—SLC22A8—renal system—muscle cancer	0.00125	0.04	CbGeAlD
Cefazolin—Pancytopenia—Etoposide—muscle cancer	0.00125	0.00636	CcSEcCtD
Cefazolin—Jaundice cholestatic—Doxorubicin—muscle cancer	0.00124	0.0063	CcSEcCtD
Cefazolin—Neutropenia—Etoposide—muscle cancer	0.00123	0.00626	CcSEcCtD
Cefazolin—Vaginal infection—Methotrexate—muscle cancer	0.00119	0.00604	CcSEcCtD
Cefazolin—Aplastic anaemia—Methotrexate—muscle cancer	0.00118	0.006	CcSEcCtD
Cefazolin—Anaemia—Dactinomycin—muscle cancer	0.00117	0.00596	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00116	0.00592	CcSEcCtD
Cefazolin—Renal failure—Etoposide—muscle cancer	0.00115	0.00587	CcSEcCtD
Cefazolin—Blood bilirubin increased—Doxorubicin—muscle cancer	0.00115	0.00585	CcSEcCtD
Cefazolin—Stomatitis—Etoposide—muscle cancer	0.00114	0.00582	CcSEcCtD
Cefazolin—Creatinine increased—Doxorubicin—muscle cancer	0.00114	0.00582	CcSEcCtD
Cefazolin—Mouth ulceration—Methotrexate—muscle cancer	0.00114	0.00578	CcSEcCtD
Cefazolin—Leukopenia—Dactinomycin—muscle cancer	0.00113	0.00577	CcSEcCtD
Cefazolin—Agranulocytosis—Etoposide—muscle cancer	0.0011	0.00557	CcSEcCtD
Cefazolin—Vaginal inflammation—Doxorubicin—muscle cancer	0.00109	0.00554	CcSEcCtD
Cefazolin—Anaemia—Vincristine—muscle cancer	0.00105	0.00532	CcSEcCtD
Cefazolin—Colitis—Doxorubicin—muscle cancer	0.00104	0.00532	CcSEcCtD
Cefazolin—Agitation—Vincristine—muscle cancer	0.00104	0.00529	CcSEcCtD
Cefazolin—Candida infection—Doxorubicin—muscle cancer	0.00104	0.00529	CcSEcCtD
Cefazolin—Vaginal infection—Doxorubicin—muscle cancer	0.00103	0.00523	CcSEcCtD
Cefazolin—Blood urea increased—Doxorubicin—muscle cancer	0.00103	0.00523	CcSEcCtD
Cefazolin—Aplastic anaemia—Doxorubicin—muscle cancer	0.00102	0.0052	CcSEcCtD
Cefazolin—Leukopenia—Vincristine—muscle cancer	0.00101	0.00516	CcSEcCtD
Cefazolin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00101	0.00515	CcSEcCtD
Cefazolin—Erythema multiforme—Etoposide—muscle cancer	0.000996	0.00507	CcSEcCtD
Cefazolin—Anorexia—Dactinomycin—muscle cancer	0.000986	0.00502	CcSEcCtD
Cefazolin—ABCC4—tendon—muscle cancer	0.000984	0.0314	CbGeAlD
Cefazolin—Mouth ulceration—Doxorubicin—muscle cancer	0.000984	0.00501	CcSEcCtD
Cefazolin—Convulsion—Vincristine—muscle cancer	0.000981	0.00499	CcSEcCtD
Cefazolin—Hypertonia—Doxorubicin—muscle cancer	0.000954	0.00485	CcSEcCtD
Cefazolin—ABCC4—bone marrow—muscle cancer	0.000953	0.0305	CbGeAlD
Cefazolin—Anaphylactic shock—Vincristine—muscle cancer	0.000924	0.0047	CcSEcCtD
Cefazolin—Phlebitis—Doxorubicin—muscle cancer	0.000917	0.00467	CcSEcCtD
Cefazolin—Thrombocytopenia—Vincristine—muscle cancer	0.000905	0.0046	CcSEcCtD
Cefazolin—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000904	0.0046	CcSEcCtD
Cefazolin—Decreased appetite—Dactinomycin—muscle cancer	0.000899	0.00457	CcSEcCtD
Cefazolin—Fatigue—Dactinomycin—muscle cancer	0.000892	0.00454	CcSEcCtD
Cefazolin—Pain—Dactinomycin—muscle cancer	0.000884	0.0045	CcSEcCtD
Cefazolin—Anorexia—Vincristine—muscle cancer	0.000881	0.00448	CcSEcCtD
Cefazolin—Hypotension—Vincristine—muscle cancer	0.000863	0.00439	CcSEcCtD
Cefazolin—Feeling abnormal—Dactinomycin—muscle cancer	0.000852	0.00434	CcSEcCtD
Cefazolin—Anaemia—Etoposide—muscle cancer	0.000848	0.00431	CcSEcCtD
Cefazolin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000846	0.0043	CcSEcCtD
Cefazolin—ABCC4—head—muscle cancer	0.000844	0.0269	CbGeAlD
Cefazolin—ALB—testis—muscle cancer	0.000842	0.0269	CbGeAlD
Cefazolin—SLC22A8—head—muscle cancer	0.000837	0.0267	CbGeAlD
Cefazolin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000821	0.00418	CcSEcCtD
Cefazolin—Leukopenia—Etoposide—muscle cancer	0.000821	0.00418	CcSEcCtD
Cefazolin—Abdominal pain—Dactinomycin—muscle cancer	0.000818	0.00416	CcSEcCtD
Cefazolin—Body temperature increased—Dactinomycin—muscle cancer	0.000818	0.00416	CcSEcCtD
Cefazolin—ABCC4—testis—muscle cancer	0.000815	0.026	CbGeAlD
Cefazolin—Loss of consciousness—Etoposide—muscle cancer	0.000806	0.0041	CcSEcCtD
Cefazolin—Decreased appetite—Vincristine—muscle cancer	0.000803	0.00409	CcSEcCtD
Cefazolin—Fatigue—Vincristine—muscle cancer	0.000797	0.00405	CcSEcCtD
Cefazolin—Convulsion—Etoposide—muscle cancer	0.000795	0.00404	CcSEcCtD
Cefazolin—Pain—Vincristine—muscle cancer	0.00079	0.00402	CcSEcCtD
Cefazolin—Eosinophilia—Methotrexate—muscle cancer	0.000781	0.00397	CcSEcCtD
Cefazolin—Hypersensitivity—Dactinomycin—muscle cancer	0.000762	0.00388	CcSEcCtD
Cefazolin—Gastrointestinal pain—Vincristine—muscle cancer	0.000756	0.00384	CcSEcCtD
Cefazolin—Confusional state—Etoposide—muscle cancer	0.000755	0.00384	CcSEcCtD
Cefazolin—Pancytopenia—Methotrexate—muscle cancer	0.000749	0.00381	CcSEcCtD
Cefazolin—Anaphylactic shock—Etoposide—muscle cancer	0.000749	0.00381	CcSEcCtD
Cefazolin—Asthenia—Dactinomycin—muscle cancer	0.000742	0.00378	CcSEcCtD
Cefazolin—Blood creatinine increased—Doxorubicin—muscle cancer	0.00074	0.00377	CcSEcCtD
Cefazolin—Neutropenia—Methotrexate—muscle cancer	0.000737	0.00375	CcSEcCtD
Cefazolin—Thrombocytopenia—Etoposide—muscle cancer	0.000733	0.00373	CcSEcCtD
Cefazolin—Abdominal pain—Vincristine—muscle cancer	0.00073	0.00372	CcSEcCtD
Cefazolin—Body temperature increased—Vincristine—muscle cancer	0.00073	0.00372	CcSEcCtD
Cefazolin—Abdominal pain upper—Doxorubicin—muscle cancer	0.000721	0.00367	CcSEcCtD
Cefazolin—Anorexia—Etoposide—muscle cancer	0.000714	0.00363	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000711	0.00362	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000711	0.00362	CcSEcCtD
Cefazolin—Diarrhoea—Dactinomycin—muscle cancer	0.000708	0.0036	CcSEcCtD
Cefazolin—Hypotension—Etoposide—muscle cancer	0.000699	0.00356	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000697	0.00355	CcSEcCtD
Cefazolin—Renal failure—Methotrexate—muscle cancer	0.000691	0.00352	CcSEcCtD
Cefazolin—Stomatitis—Methotrexate—muscle cancer	0.000685	0.00349	CcSEcCtD
Cefazolin—Hypersensitivity—Vincristine—muscle cancer	0.000681	0.00346	CcSEcCtD
Cefazolin—Eosinophilia—Doxorubicin—muscle cancer	0.000676	0.00344	CcSEcCtD
Cefazolin—Somnolence—Etoposide—muscle cancer	0.000665	0.00339	CcSEcCtD
Cefazolin—Asthenia—Vincristine—muscle cancer	0.000663	0.00337	CcSEcCtD
Cefazolin—Vomiting—Dactinomycin—muscle cancer	0.000658	0.00335	CcSEcCtD
Cefazolin—Agranulocytosis—Methotrexate—muscle cancer	0.000656	0.00334	CcSEcCtD
Cefazolin—Rash—Dactinomycin—muscle cancer	0.000652	0.00332	CcSEcCtD
Cefazolin—Decreased appetite—Etoposide—muscle cancer	0.000651	0.00331	CcSEcCtD
Cefazolin—Pancytopenia—Doxorubicin—muscle cancer	0.000648	0.0033	CcSEcCtD
Cefazolin—Fatigue—Etoposide—muscle cancer	0.000645	0.00328	CcSEcCtD
Cefazolin—Pain—Etoposide—muscle cancer	0.00064	0.00326	CcSEcCtD
Cefazolin—Neutropenia—Doxorubicin—muscle cancer	0.000638	0.00325	CcSEcCtD
Cefazolin—Haemoglobin—Methotrexate—muscle cancer	0.000634	0.00323	CcSEcCtD
Cefazolin—Diarrhoea—Vincristine—muscle cancer	0.000632	0.00322	CcSEcCtD
Cefazolin—Haemorrhage—Methotrexate—muscle cancer	0.000631	0.00321	CcSEcCtD
Cefazolin—Hepatitis—Methotrexate—muscle cancer	0.000631	0.00321	CcSEcCtD
Cefazolin—Feeling abnormal—Etoposide—muscle cancer	0.000617	0.00314	CcSEcCtD
Cefazolin—Nausea—Dactinomycin—muscle cancer	0.000614	0.00313	CcSEcCtD
Cefazolin—Gastrointestinal pain—Etoposide—muscle cancer	0.000612	0.00311	CcSEcCtD
Cefazolin—Dizziness—Vincristine—muscle cancer	0.000611	0.00311	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000604	0.00307	CcSEcCtD
Cefazolin—Renal failure—Doxorubicin—muscle cancer	0.000598	0.00304	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—muscle cancer	0.000597	0.00304	CcSEcCtD
Cefazolin—Urticaria—Etoposide—muscle cancer	0.000595	0.00303	CcSEcCtD
Cefazolin—Stomatitis—Doxorubicin—muscle cancer	0.000593	0.00302	CcSEcCtD
Cefazolin—Body temperature increased—Etoposide—muscle cancer	0.000592	0.00301	CcSEcCtD
Cefazolin—Abdominal pain—Etoposide—muscle cancer	0.000592	0.00301	CcSEcCtD
Cefazolin—Vomiting—Vincristine—muscle cancer	0.000588	0.00299	CcSEcCtD
Cefazolin—Rash—Vincristine—muscle cancer	0.000583	0.00296	CcSEcCtD
Cefazolin—Dermatitis—Vincristine—muscle cancer	0.000582	0.00296	CcSEcCtD
Cefazolin—Headache—Vincristine—muscle cancer	0.000579	0.00295	CcSEcCtD
Cefazolin—Agranulocytosis—Doxorubicin—muscle cancer	0.000568	0.00289	CcSEcCtD
Cefazolin—Hypersensitivity—Etoposide—muscle cancer	0.000552	0.00281	CcSEcCtD
Cefazolin—Haemoglobin—Doxorubicin—muscle cancer	0.000549	0.00279	CcSEcCtD
Cefazolin—Nausea—Vincristine—muscle cancer	0.000549	0.00279	CcSEcCtD
Cefazolin—Haemorrhage—Doxorubicin—muscle cancer	0.000546	0.00278	CcSEcCtD
Cefazolin—Hepatitis—Doxorubicin—muscle cancer	0.000546	0.00278	CcSEcCtD
Cefazolin—Asthenia—Etoposide—muscle cancer	0.000537	0.00273	CcSEcCtD
Cefazolin—Pruritus—Etoposide—muscle cancer	0.00053	0.00269	CcSEcCtD
Cefazolin—Erythema multiforme—Doxorubicin—muscle cancer	0.000517	0.00263	CcSEcCtD
Cefazolin—Diarrhoea—Etoposide—muscle cancer	0.000512	0.00261	CcSEcCtD
Cefazolin—Anaemia—Methotrexate—muscle cancer	0.000508	0.00258	CcSEcCtD
Cefazolin—Dizziness—Etoposide—muscle cancer	0.000495	0.00252	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—muscle cancer	0.000492	0.0025	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—muscle cancer	0.000476	0.00242	CcSEcCtD
Cefazolin—Vomiting—Etoposide—muscle cancer	0.000476	0.00242	CcSEcCtD
Cefazolin—Rash—Etoposide—muscle cancer	0.000472	0.0024	CcSEcCtD
Cefazolin—Dermatitis—Etoposide—muscle cancer	0.000472	0.0024	CcSEcCtD
Cefazolin—Headache—Etoposide—muscle cancer	0.000469	0.00239	CcSEcCtD
Cefazolin—Flatulence—Doxorubicin—muscle cancer	0.000469	0.00239	CcSEcCtD
Cefazolin—Confusional state—Methotrexate—muscle cancer	0.000452	0.0023	CcSEcCtD
Cefazolin—Anaphylactic shock—Methotrexate—muscle cancer	0.000448	0.00228	CcSEcCtD
Cefazolin—Nausea—Etoposide—muscle cancer	0.000445	0.00226	CcSEcCtD
Cefazolin—Anaemia—Doxorubicin—muscle cancer	0.00044	0.00224	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—muscle cancer	0.000439	0.00223	CcSEcCtD
Cefazolin—Agitation—Doxorubicin—muscle cancer	0.000437	0.00222	CcSEcCtD
Cefazolin—Anorexia—Methotrexate—muscle cancer	0.000427	0.00217	CcSEcCtD
Cefazolin—Syncope—Doxorubicin—muscle cancer	0.000427	0.00217	CcSEcCtD
Cefazolin—Leukopenia—Doxorubicin—muscle cancer	0.000426	0.00217	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—muscle cancer	0.000419	0.00213	CcSEcCtD
Cefazolin—Loss of consciousness—Doxorubicin—muscle cancer	0.000418	0.00213	CcSEcCtD
Cefazolin—Convulsion—Doxorubicin—muscle cancer	0.000412	0.0021	CcSEcCtD
Cefazolin—Somnolence—Methotrexate—muscle cancer	0.000399	0.00203	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—muscle cancer	0.000395	0.00201	CcSEcCtD
Cefazolin—Confusional state—Doxorubicin—muscle cancer	0.000391	0.00199	CcSEcCtD
Cefazolin—Decreased appetite—Methotrexate—muscle cancer	0.00039	0.00198	CcSEcCtD
Cefazolin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000388	0.00198	CcSEcCtD
Cefazolin—Fatigue—Methotrexate—muscle cancer	0.000387	0.00197	CcSEcCtD
Cefazolin—Pain—Methotrexate—muscle cancer	0.000383	0.00195	CcSEcCtD
Cefazolin—Shock—Doxorubicin—muscle cancer	0.000382	0.00194	CcSEcCtD
Cefazolin—Thrombocytopenia—Doxorubicin—muscle cancer	0.00038	0.00193	CcSEcCtD
Cefazolin—Anorexia—Doxorubicin—muscle cancer	0.00037	0.00188	CcSEcCtD
Cefazolin—Feeling abnormal—Methotrexate—muscle cancer	0.000369	0.00188	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000367	0.00187	CcSEcCtD
Cefazolin—Hypotension—Doxorubicin—muscle cancer	0.000363	0.00185	CcSEcCtD
Cefazolin—Urticaria—Methotrexate—muscle cancer	0.000356	0.00181	CcSEcCtD
Cefazolin—Abdominal pain—Methotrexate—muscle cancer	0.000354	0.0018	CcSEcCtD
Cefazolin—Body temperature increased—Methotrexate—muscle cancer	0.000354	0.0018	CcSEcCtD
Cefazolin—Somnolence—Doxorubicin—muscle cancer	0.000345	0.00176	CcSEcCtD
Cefazolin—Dyspepsia—Doxorubicin—muscle cancer	0.000342	0.00174	CcSEcCtD
Cefazolin—Decreased appetite—Doxorubicin—muscle cancer	0.000338	0.00172	CcSEcCtD
Cefazolin—Fatigue—Doxorubicin—muscle cancer	0.000335	0.0017	CcSEcCtD
Cefazolin—Pain—Doxorubicin—muscle cancer	0.000332	0.00169	CcSEcCtD
Cefazolin—Hypersensitivity—Methotrexate—muscle cancer	0.00033	0.00168	CcSEcCtD
Cefazolin—Asthenia—Methotrexate—muscle cancer	0.000322	0.00164	CcSEcCtD
Cefazolin—Feeling abnormal—Doxorubicin—muscle cancer	0.00032	0.00163	CcSEcCtD
Cefazolin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000317	0.00162	CcSEcCtD
Cefazolin—Pruritus—Methotrexate—muscle cancer	0.000317	0.00161	CcSEcCtD
Cefazolin—Urticaria—Doxorubicin—muscle cancer	0.000308	0.00157	CcSEcCtD
Cefazolin—Body temperature increased—Doxorubicin—muscle cancer	0.000307	0.00156	CcSEcCtD
Cefazolin—Abdominal pain—Doxorubicin—muscle cancer	0.000307	0.00156	CcSEcCtD
Cefazolin—Diarrhoea—Methotrexate—muscle cancer	0.000307	0.00156	CcSEcCtD
Cefazolin—Dizziness—Methotrexate—muscle cancer	0.000297	0.00151	CcSEcCtD
Cefazolin—Hypersensitivity—Doxorubicin—muscle cancer	0.000286	0.00146	CcSEcCtD
Cefazolin—Vomiting—Methotrexate—muscle cancer	0.000285	0.00145	CcSEcCtD
Cefazolin—Rash—Methotrexate—muscle cancer	0.000283	0.00144	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—muscle cancer	0.000282	0.00144	CcSEcCtD
Cefazolin—Headache—Methotrexate—muscle cancer	0.000281	0.00143	CcSEcCtD
Cefazolin—Asthenia—Doxorubicin—muscle cancer	0.000279	0.00142	CcSEcCtD
Cefazolin—Pruritus—Doxorubicin—muscle cancer	0.000275	0.0014	CcSEcCtD
Cefazolin—Nausea—Methotrexate—muscle cancer	0.000266	0.00136	CcSEcCtD
Cefazolin—Diarrhoea—Doxorubicin—muscle cancer	0.000266	0.00135	CcSEcCtD
Cefazolin—Dizziness—Doxorubicin—muscle cancer	0.000257	0.00131	CcSEcCtD
Cefazolin—Vomiting—Doxorubicin—muscle cancer	0.000247	0.00126	CcSEcCtD
Cefazolin—Rash—Doxorubicin—muscle cancer	0.000245	0.00125	CcSEcCtD
Cefazolin—Dermatitis—Doxorubicin—muscle cancer	0.000245	0.00124	CcSEcCtD
Cefazolin—Headache—Doxorubicin—muscle cancer	0.000243	0.00124	CcSEcCtD
Cefazolin—Nausea—Doxorubicin—muscle cancer	0.000231	0.00117	CcSEcCtD
